Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients

Clinical trial NCT04817774 · COMPLETED

Trial details

NCT number: NCT04817774
Sponsor: Sangamo Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Kidney Transplant Rejection End Stage Renal Disease

Start date: 2021-03-17
Primary completion: 2024-07-11
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.